/Steve Rees
AstraZeneca Optimizes Ultra High-Throughput Drug Discovery Screening using Acoustic Liquid Handling Technology
AstraZeneca Optimizes Ultra High-Throughput Drug Discovery Screening using Acoustic Liquid Handling Technology
16 May 2023

Steve Rees, VP of screening sciences and sample management at AstraZeneca, discusses how combing acoustic liquid handling and mass spectrometry can increase throughput of samples and decrease assay development costs by up to 1000-fold. Find out how AstraZeneca’s partnership with Labcyte will impact metabolomics and drug discovery screening.

Other Videos by Steve Rees

Related Scientists

Related Content